Examkin

Question

Difficulty: MediumRheumatology and Immunology

A 28-year-old woman with a history of systemic lupus erythematosus presents to the clinic with new-onset bilateral lower extremity edema. Her blood pressure is 150/92 mm Hg. Laboratory studies show a serum creatinine of 1.5 mg/dL (baseline 0.8 mg/dL), positive anti-dsDNA antibodies, and decreased C3 and C4 levels. Urinalysis reveals 3+ protein, 15-20 red blood cells/hpf, and the presence of red blood cell casts.

Arrange the following steps in the standard chronological sequence for the definitive diagnostic evaluation and long-term pharmacologic management of this patient's renal disease.

  1. 1Perform a percutaneous renal biopsy to determine the histologic classification.
  2. 2Initiate induction therapy with high-dose glucocorticoids and a potent immunosuppressant.
  3. 3Transition to a maintenance immunosuppressive regimen once clinical remission is achieved.
  4. 4Gradually taper and attempt withdrawal of maintenance therapy after several years of sustained complete response.

Answer

The correct sequential order for managing severe lupus nephritis begins with a renal biopsy for histologic classification, followed by initiating intensive induction therapy, then transitioning to lower-dose maintenance therapy upon achieving remission, and finally attempting a cautious taper of maintenance therapy only after years of sustained complete response.
The management of suspected severe lupus nephritis strictly adheres to a phased algorithm designed to balance therapeutic efficacy with the significant toxicities of immunosuppressive medications. The sequence must begin with a renal biopsy to accurately stage the disease, as proliferative forms (Classes III and IV) require highly aggressive treatment, whereas severe chronic scarring does not respond to immunosuppression. Once active disease is confirmed, a short-term, intensive induction phase is initiated to rapidly halt renal inflammation. After disease activity is controlled (typically after 3 to 6 months), the patient is transitioned to a less toxic maintenance phase to sustain the remission. Finally, only after several years of a complete clinical and laboratory response, a gradual taper of maintenance therapy may be carefully attempted.

Step-by-Step Solution

1
Identify the clinical presentation and severity.
The patient has signs of active, severe lupus nephritis, indicated by hypertension, edema, acute kidney injury, active urine sediment, and hypocomplementemia.
Recognizing the severity of the presentation establishes the immediate need for a definitive diagnosis and an aggressive, multiphasic management approach.
2
Determine the most appropriate initial diagnostic step.
Perform a percutaneous renal biopsy.
Lupus nephritis has distinct histologic classes. Biopsy is required to differentiate between proliferative patterns (which require aggressive cytotoxic therapy) and membranous or sclerotic patterns (which have different management pathways).
3
Establish the sequence of pharmacologic management phases.
Induction therapy must precede maintenance therapy.
Severe lupus nephritis requires an initial intensive 'induction' phase to rapidly suppress active inflammation, followed by a prolonged 'maintenance' phase using lower-dose agents to prevent relapse while minimizing drug toxicity.
4
Determine the long-term management strategy.
Tapering of maintenance therapy is considered last.
Only after years of sustained complete renal response on maintenance therapy can clinicians carefully attempt to taper and withdraw immunosuppressants without a high risk of relapse.

Key Concept

Management of severe lupus nephritis follows a strictly phased approach: definitive diagnostic staging via renal biopsy, intensive induction immunosuppression, prolonged maintenance immunosuppression, and eventual cautious tapering during sustained remission.
Rate this question

Topics

Rheumatology and Immunology

More questions from this topic